Fidelis Capital Partners’s Labcorp LH Stock Holding History

Fidelis Capital Partners’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$550K	Buy	+1,963	New	+$516K	0.03%	320

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fidelis Capital Partners's LH Position: Q2 2026 in Review

Fidelis Capital Partners opened a new position in Labcorp (LH) in Q2 2026: 1,963 shares worth $550K. The stake represents 0.03% of the portfolio and ranks #320 among its holdings.

1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Fidelis Capital Partners held 1,963 shares of Labcorp worth $550K as of Q2 2026.
Labcorp was a new Fidelis Capital Partners position in Q2 2026.
Labcorp made up 0.03% of Fidelis Capital Partners's portfolio in Q2 2026, its #320 holding.
1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.